 Robert Ryu
Concepts (501)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 64 | 6.250 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 242 | 3.190 |
Why?
| | Liver Neoplasms | 60 | 2014 | 780 | 3.060 |
Why?
| | Device Removal | 18 | 2023 | 142 | 3.050 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 64 | 2.760 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 38 | 2.750 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 370 | 2.420 |
Why?
| | Radiology, Interventional | 6 | 2024 | 49 | 2.320 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 243 | 1.810 |
Why?
| | Radiography, Interventional | 17 | 2016 | 130 | 1.550 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 36 | 1.470 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 89 | 1.440 |
Why?
| | Hypertension, Portal | 5 | 2016 | 66 | 1.270 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 194 | 1.250 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 252 | 1.200 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 96 | 1.090 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 81 | 0.990 |
Why?
| | Educational Measurement | 2 | 2020 | 325 | 0.970 |
Why?
| | Venous Thrombosis | 6 | 2023 | 194 | 0.950 |
Why?
| | Lasers, Excimer | 2 | 2022 | 30 | 0.910 |
Why?
| | Renal Dialysis | 2 | 2020 | 462 | 0.880 |
Why?
| | Treatment Outcome | 71 | 2023 | 11643 | 0.870 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1347 | 0.860 |
Why?
| | Portal Vein | 4 | 2016 | 114 | 0.860 |
Why?
| | Microspheres | 29 | 2013 | 142 | 0.850 |
Why?
| | Prosthesis Design | 7 | 2020 | 354 | 0.810 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 29 | 0.780 |
Why?
| | Leiomyoma | 9 | 2007 | 59 | 0.760 |
Why?
| | Specialty Boards | 2 | 2020 | 42 | 0.760 |
Why?
| | Total Disc Replacement | 2 | 2020 | 12 | 0.760 |
Why?
| | Intervertebral Disc | 3 | 2020 | 36 | 0.740 |
Why?
| | Uterus | 7 | 2007 | 226 | 0.730 |
Why?
| | Postoperative Complications | 8 | 2021 | 2916 | 0.730 |
Why?
| | Forecasting | 1 | 2024 | 388 | 0.720 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 94 | 0.720 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.690 |
Why?
| | Saphenous Vein | 3 | 2007 | 37 | 0.680 |
Why?
| | Thromboembolism | 3 | 2017 | 125 | 0.660 |
Why?
| | Middle Aged | 87 | 2026 | 35762 | 0.630 |
Why?
| | Spinal Fusion | 3 | 2021 | 260 | 0.630 |
Why?
| | Medicare | 3 | 2020 | 881 | 0.620 |
Why?
| | Humans | 152 | 2026 | 144261 | 0.620 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 153 | 0.610 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 41 | 0.600 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 338 | 0.600 |
Why?
| | Laser Therapy | 3 | 2007 | 135 | 0.600 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 70 | 0.580 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 42 | 0.570 |
Why?
| | Medicine | 1 | 2020 | 125 | 0.570 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 251 | 0.560 |
Why?
| | Endovascular Procedures | 5 | 2020 | 384 | 0.560 |
Why?
| | Low Back Pain | 1 | 2020 | 106 | 0.560 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 324 | 0.540 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.540 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 219 | 0.530 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 160 | 0.520 |
Why?
| | Spine | 1 | 2019 | 182 | 0.520 |
Why?
| | Female | 103 | 2026 | 77976 | 0.510 |
Why?
| | Ascites | 2 | 2016 | 49 | 0.510 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 72 | 0.500 |
Why?
| | Time Factors | 25 | 2021 | 7155 | 0.500 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3857 | 0.500 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 136 | 0.500 |
Why?
| | Tomography, X-Ray Computed | 25 | 2026 | 2730 | 0.490 |
Why?
| | Aged | 64 | 2026 | 25850 | 0.480 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 242 | 0.480 |
Why?
| | Stents | 8 | 2015 | 556 | 0.480 |
Why?
| | Retrospective Studies | 37 | 2023 | 17009 | 0.470 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 33 | 0.460 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 9 | 0.460 |
Why?
| | Brachytherapy | 8 | 2008 | 134 | 0.450 |
Why?
| | Aged, 80 and over | 34 | 2021 | 8243 | 0.450 |
Why?
| | Male | 88 | 2026 | 72035 | 0.450 |
Why?
| | Cholestasis | 2 | 2015 | 219 | 0.440 |
Why?
| | Adult | 59 | 2021 | 40262 | 0.430 |
Why?
| | Social Media | 1 | 2017 | 171 | 0.430 |
Why?
| | United States | 17 | 2026 | 15876 | 0.420 |
Why?
| | Radiology | 2 | 2024 | 173 | 0.410 |
Why?
| | Radiation Dosage | 6 | 2020 | 192 | 0.400 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 26 | 0.370 |
Why?
| | Thrombosis | 4 | 2022 | 393 | 0.370 |
Why?
| | Clinical Competence | 2 | 2019 | 1241 | 0.360 |
Why?
| | Ovary | 3 | 2003 | 228 | 0.360 |
Why?
| | Angiography | 11 | 2011 | 207 | 0.350 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 582 | 0.340 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 288 | 0.340 |
Why?
| | Risk Factors | 18 | 2020 | 10699 | 0.330 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 9 | 0.320 |
Why?
| | Vascular System Injuries | 3 | 2016 | 77 | 0.320 |
Why?
| | Perfusion Imaging | 1 | 2010 | 65 | 0.310 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 105 | 0.310 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 237 | 0.310 |
Why?
| | Drainage | 3 | 2019 | 185 | 0.310 |
Why?
| | Angioplasty | 3 | 2007 | 50 | 0.310 |
Why?
| | Chicago | 6 | 2017 | 61 | 0.310 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 6 | 0.310 |
Why?
| | Liver Abscess | 1 | 2009 | 5 | 0.300 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 167 | 0.300 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 2111 | 0.300 |
Why?
| | Observer Variation | 3 | 2010 | 354 | 0.300 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 18 | 0.300 |
Why?
| | Thyroid Gland | 1 | 2009 | 88 | 0.290 |
Why?
| | Hepatic Veins | 1 | 2008 | 32 | 0.290 |
Why?
| | Rabbits | 12 | 2020 | 648 | 0.290 |
Why?
| | Phlebography | 6 | 2015 | 39 | 0.280 |
Why?
| | Neoplasms | 5 | 2023 | 2870 | 0.280 |
Why?
| | Contrast Media | 12 | 2016 | 486 | 0.280 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 286 | 0.270 |
Why?
| | Portography | 4 | 2016 | 7 | 0.270 |
Why?
| | Gelatin | 2 | 2005 | 56 | 0.270 |
Why?
| | Liver Transplantation | 5 | 2015 | 822 | 0.260 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 5 | 0.260 |
Why?
| | Prosthesis Failure | 3 | 2017 | 125 | 0.260 |
Why?
| | Databases, Factual | 7 | 2020 | 1484 | 0.260 |
Why?
| | Catheterization | 7 | 2013 | 183 | 0.260 |
Why?
| | Aortography | 1 | 2007 | 52 | 0.260 |
Why?
| | Patient Selection | 6 | 2020 | 719 | 0.250 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 918 | 0.250 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2192 | 0.250 |
Why?
| | Logistic Models | 8 | 2021 | 2104 | 0.250 |
Why?
| | Hepatic Artery | 5 | 2010 | 53 | 0.250 |
Why?
| | Linear Models | 4 | 2017 | 850 | 0.240 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 162 | 0.240 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 127 | 0.240 |
Why?
| | Referral and Consultation | 1 | 2012 | 847 | 0.240 |
Why?
| | Acrylic Resins | 1 | 2005 | 45 | 0.230 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 343 | 0.230 |
Why?
| | Radiation Injuries | 5 | 2010 | 151 | 0.220 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 228 | 0.220 |
Why?
| | Blister | 1 | 2004 | 39 | 0.210 |
Why?
| | Arteries | 7 | 2013 | 258 | 0.210 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1533 | 0.210 |
Why?
| | Prospective Studies | 17 | 2026 | 7970 | 0.200 |
Why?
| | Cohort Studies | 7 | 2023 | 5935 | 0.200 |
Why?
| | Internship and Residency | 2 | 2019 | 1255 | 0.200 |
Why?
| | Survival Rate | 12 | 2018 | 2088 | 0.200 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 2 | 0.200 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 13 | 0.190 |
Why?
| | Jugular Veins | 3 | 1997 | 42 | 0.190 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1461 | 0.180 |
Why?
| | Fluoroscopy | 2 | 2016 | 176 | 0.180 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 56 | 0.180 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 131 | 0.180 |
Why?
| | Catheters | 3 | 2023 | 75 | 0.180 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 173 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 964 | 0.180 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1050 | 0.180 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 527 | 0.170 |
Why?
| | Disease Progression | 14 | 2014 | 2840 | 0.170 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 248 | 0.170 |
Why?
| | Bone-Implant Interface | 1 | 2021 | 3 | 0.170 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 48 | 0.170 |
Why?
| | Vascular Patency | 3 | 2018 | 120 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 402 | 0.170 |
Why?
| | Liver | 7 | 2013 | 1884 | 0.170 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 37 | 0.170 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 40 | 0.160 |
Why?
| | Reoperation | 4 | 2019 | 629 | 0.160 |
Why?
| | Surgical Stomas | 1 | 2000 | 10 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 462 | 0.160 |
Why?
| | Colostomy | 1 | 2000 | 28 | 0.160 |
Why?
| | Liver Diseases | 2 | 2007 | 304 | 0.160 |
Why?
| | Varicose Veins | 1 | 2000 | 16 | 0.160 |
Why?
| | Adolescent | 16 | 2021 | 22281 | 0.160 |
Why?
| | Catheter Ablation | 1 | 2004 | 353 | 0.160 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4556 | 0.160 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 61 | 0.160 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1983 | 0.160 |
Why?
| | Medical Oncology | 2 | 2013 | 331 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 218 | 0.150 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 117 | 0.150 |
Why?
| | Lumbosacral Region | 1 | 2020 | 59 | 0.150 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.150 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 15 | 0.150 |
Why?
| | Laminoplasty | 1 | 2019 | 2 | 0.150 |
Why?
| | Laminectomy | 1 | 2019 | 31 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 285 | 0.150 |
Why?
| | Follow-Up Studies | 11 | 2013 | 5389 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 67 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 134 | 0.140 |
Why?
| | Iliac Artery | 2 | 2018 | 55 | 0.140 |
Why?
| | Ohio | 1 | 2019 | 140 | 0.140 |
Why?
| | Glass | 3 | 2013 | 45 | 0.140 |
Why?
| | Hemorrhage | 2 | 2023 | 809 | 0.140 |
Why?
| | Models, Educational | 1 | 2019 | 88 | 0.140 |
Why?
| | Survival Analysis | 6 | 2011 | 1382 | 0.140 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 182 | 0.140 |
Why?
| | Young Adult | 8 | 2021 | 13990 | 0.140 |
Why?
| | Biliary Fistula | 1 | 1998 | 4 | 0.140 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 154 | 0.140 |
Why?
| | Intestine, Small | 1 | 2019 | 166 | 0.140 |
Why?
| | Mesenteric Veins | 1 | 1998 | 23 | 0.140 |
Why?
| | Fibrin | 2 | 2023 | 91 | 0.130 |
Why?
| | Pain | 1 | 2003 | 777 | 0.130 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 276 | 0.130 |
Why?
| | Writing | 1 | 2019 | 100 | 0.130 |
Why?
| | Thrombectomy | 1 | 1998 | 77 | 0.130 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 203 | 0.130 |
Why?
| | Liver Circulation | 4 | 2015 | 12 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2026 | 2926 | 0.130 |
Why?
| | Radiography | 7 | 2012 | 842 | 0.130 |
Why?
| | Treatment Failure | 4 | 2017 | 363 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 73 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 166 | 0.120 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 25 | 0.120 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 27 | 0.120 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.120 |
Why?
| | History, 20th Century | 1 | 2017 | 324 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2917 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 727 | 0.120 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 31 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 67 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 39 | 0.120 |
Why?
| | Research Design | 3 | 2013 | 1129 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2019 | 545 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 68 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 438 | 0.120 |
Why?
| | Stomach | 2 | 2013 | 109 | 0.110 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3539 | 0.110 |
Why?
| | Models, Anatomic | 1 | 2016 | 84 | 0.110 |
Why?
| | Patient Readmission | 1 | 2021 | 756 | 0.110 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3403 | 0.110 |
Why?
| | Doxorubicin | 3 | 2013 | 397 | 0.110 |
Why?
| | Operative Time | 1 | 2016 | 175 | 0.110 |
Why?
| | Radiation Exposure | 1 | 2016 | 63 | 0.110 |
Why?
| | Biomarkers, Tumor | 4 | 2026 | 1313 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 62 | 0.110 |
Why?
| | Aorta | 1 | 2018 | 429 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 316 | 0.110 |
Why?
| | Necrosis | 5 | 2020 | 244 | 0.110 |
Why?
| | Dilatation | 1 | 2015 | 72 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2016 | 155 | 0.110 |
Why?
| | Hospital Mortality | 2 | 2018 | 1027 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1075 | 0.110 |
Why?
| | Sex Factors | 2 | 2018 | 2096 | 0.110 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 39 | 0.110 |
Why?
| | Cisplatin | 3 | 2012 | 334 | 0.110 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 371 | 0.110 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 32 | 0.100 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 258 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2016 | 242 | 0.100 |
Why?
| | Length of Stay | 2 | 2019 | 1335 | 0.100 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 557 | 0.100 |
Why?
| | Kidney Diseases | 1 | 1998 | 425 | 0.100 |
Why?
| | Stress, Mechanical | 1 | 2016 | 494 | 0.100 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 28 | 0.100 |
Why?
| | Duodenum | 1 | 2013 | 77 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 768 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 503 | 0.100 |
Why?
| | Anticoagulants | 2 | 2017 | 721 | 0.100 |
Why?
| | Arthroscopy | 3 | 1992 | 267 | 0.100 |
Why?
| | Prevalence | 3 | 2021 | 2815 | 0.090 |
Why?
| | Regional Blood Flow | 3 | 2007 | 512 | 0.090 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 117 | 0.090 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 842 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2017 | 777 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2026 | 2637 | 0.090 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1322 | 0.090 |
Why?
| | Shoulder Injuries | 1 | 1992 | 66 | 0.090 |
Why?
| | Acromion | 1 | 1992 | 8 | 0.090 |
Why?
| | Electroporation | 1 | 2012 | 41 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1953 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 8 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 73 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 59 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1646 | 0.080 |
Why?
| | Animals | 15 | 2021 | 38030 | 0.080 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.080 |
Why?
| | Prognosis | 5 | 2010 | 4278 | 0.080 |
Why?
| | Research Report | 1 | 2011 | 87 | 0.080 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 26 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 84 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 319 | 0.080 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 112 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 40 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1559 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 68 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 454 | 0.080 |
Why?
| | Recurrence | 3 | 2021 | 1134 | 0.070 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 18 | 0.070 |
Why?
| | Gastrostomy | 2 | 2009 | 130 | 0.070 |
Why?
| | Bilirubin | 3 | 2010 | 97 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 106 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 31 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 14 | 0.070 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2447 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 289 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 264 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 16 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 122 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 26 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1487 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 251 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 83 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 4 | 0.060 |
Why?
| | Acute Disease | 2 | 2021 | 1028 | 0.060 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 40 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2008 | 175 | 0.060 |
Why?
| | Incidence | 3 | 2009 | 2870 | 0.060 |
Why?
| | Image Enhancement | 4 | 2011 | 199 | 0.060 |
Why?
| | Radiotherapy | 1 | 2008 | 206 | 0.060 |
Why?
| | Leiomyomatosis | 1 | 2006 | 4 | 0.060 |
Why?
| | Palliative Care | 1 | 2015 | 996 | 0.060 |
Why?
| | Credentialing | 1 | 2006 | 21 | 0.060 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 122 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 297 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 336 | 0.060 |
Why?
| | France | 1 | 2026 | 40 | 0.060 |
Why?
| | Iron | 1 | 2008 | 359 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 329 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 31 | 0.060 |
Why?
| | Knee Joint | 1 | 1989 | 426 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 93 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 462 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2424 | 0.050 |
Why?
| | Decision Making | 1 | 2012 | 974 | 0.050 |
Why?
| | Kidney Transplantation | 1 | 2011 | 704 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 120 | 0.050 |
Why?
| | Postmenopause | 1 | 2007 | 391 | 0.050 |
Why?
| | Heart Failure | 1 | 2018 | 2314 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1264 | 0.050 |
Why?
| | Odds Ratio | 2 | 2017 | 1072 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 140 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 16 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1867 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 421 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 15 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 45 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 38 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 45 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 355 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 78 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 88 | 0.050 |
Why?
| | Elasticity | 1 | 2022 | 184 | 0.050 |
Why?
| | Pelvis | 1 | 2002 | 124 | 0.040 |
Why?
| | Drug Stability | 2 | 2013 | 164 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2013 | 333 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 103 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 844 | 0.040 |
Why?
| | Feasibility Studies | 3 | 2011 | 1087 | 0.040 |
Why?
| | Hepatectomy | 2 | 2013 | 273 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 106 | 0.040 |
Why?
| | Osseointegration | 1 | 2021 | 60 | 0.040 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2021 | 59 | 0.040 |
Why?
| | Europe | 2 | 2012 | 412 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 629 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 150 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 28 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 369 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 44 | 0.040 |
Why?
| | Neural Crest | 1 | 2021 | 126 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 47 | 0.040 |
Why?
| | Skull | 1 | 2021 | 155 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 768 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 320 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 60 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 25 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 79 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 729 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 140 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 610 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 71 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 38 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 83 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 157 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1304 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 124 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 147 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 9 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 530 | 0.030 |
Why?
| | Ethiodized Oil | 2 | 2008 | 10 | 0.030 |
Why?
| | Mitomycin | 2 | 2008 | 32 | 0.030 |
Why?
| | Swine | 2 | 2016 | 831 | 0.030 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 104 | 0.030 |
Why?
| | Guidelines as Topic | 2 | 2010 | 267 | 0.030 |
Why?
| | Population Surveillance | 1 | 2001 | 483 | 0.030 |
Why?
| | Nervous System Diseases | 2 | 2017 | 282 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 45 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 41 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 464 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 127 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 130 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 131 | 0.030 |
Why?
| | Demography | 1 | 2017 | 284 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 171 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 323 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 71 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 706 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3592 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 291 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 338 | 0.030 |
Why?
| | Lung | 1 | 2008 | 4108 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 195 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 597 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 542 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 158 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 111 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 48 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 555 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 379 | 0.020 |
Why?
| | Ablation Techniques | 1 | 2013 | 36 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2021 | 2048 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 339 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2013 | 68 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 222 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 48 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 108 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 130 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 30 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4254 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 77 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 192 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 146 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 80 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3637 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 462 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 143 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 316 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5813 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1812 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3313 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 421 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 361 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 36 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2382 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 54 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 255 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 612 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 3 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 33 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 23 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 7 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 327 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 8 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 176 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 998 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2525 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 131 | 0.020 |
Why?
| | Injections | 1 | 2008 | 196 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 18 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 128 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 20 | 0.020 |
Why?
| | Femur | 1 | 1989 | 250 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 91 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 600 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 919 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 832 | 0.010 |
Why?
| | Retreatment | 1 | 2005 | 77 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 1989 | 343 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5592 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 688 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1705 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1834 | 0.010 |
Why?
| | Mice | 1 | 2021 | 18329 | 0.010 |
Why?
| | Child | 3 | 2017 | 22537 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11774 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 44 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 413 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 392 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 84 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 52 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 16 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 59 | 0.010 |
Why?
| | Veins | 1 | 1999 | 68 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 315 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 57 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 124 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 81 | 0.010 |
Why?
| | Arm | 1 | 1999 | 109 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 82 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 133 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 64 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 47 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 76 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 68 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 130 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 65 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 282 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 213 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 216 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 116 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 94 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 102 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 199 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 243 | 0.010 |
Why?
| | HIV | 1 | 1997 | 248 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 342 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 519 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 4 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 176 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 358 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 358 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 334 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 506 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 6021 | 0.000 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 62 | 0.000 |
Why?
| | Postoperative Period | 1 | 1990 | 353 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|